Uncover the true nature of bladder cancer

Genomic Profiling for Bladder Cancer

Decipher Bladder is the only genomic subtyping tool available to physicians in the United States treating patients with locally advanced bladder cancer.

highest-reported-accuracy

Highly Accurate

in classifying bladder tumors into four molecular subtypes

comprehensive-geo

Comprehensive

genome-wide assay of 46,000 genes

innovative-pink

Innovative

model derived from the Cancer Genome Atlas project

Indicated for patients with AJCC Stage I to IIIA bladder cancer

Uses a whole transcriptome microarray to measure 219 genes

Provides the tumor molecular subtype:

Luminal
Luminal-Infiltrated
Basal
Basal Claudin-Low
Neuroendorcine-like

Developed and validated in over 1500 patients
from 28 leading cancer centers in North America and Europe

Publications

Badrinath Konety, MD

University of Minnesota

“Decipher Bladder can reveal the biological nature of the patient’s tumor. It is the most promising tool we currently have available as a potential aid in clinical decision making prior to radical cystectomy.”

Physicians \ Order a Test

Order Online:

New users:

Sign up for a new account by contacting Customer Support at:

888.792.1601 or:

cs@decipherbio.com

Current Users:

Or Order
by Fax:

1. Download and complete the appropriate Test Requisition Form below:

2. Fax the completed form, along with the pathology report and insurance information to:

1.858.766.6575

Specimen Acceptance Criteria

Decipher
Prostate Biopsy

ALL Gleason Scores

ALL PSA Values

ALL Stages

Decipher
Prostate RP

ALL Gleason Scores

ALL PSA Values (including undetectable, rising, and persistently elevated PSA)

ALL Stages

Decipher
Bladder

TURBT
(Trans-Urethral Resection
of Bladder Tumor) from AJCC Stage I to IIIA bladder cancer

Patients \ Insurance Information

Veracyte is committed to ensuring access to Decipher genomic testing for all patients.
Decipher Prostate

Decipher Prostate is covered by Medicare, Medicare Advantage and select private insurers.

Through Decipher Assist, we offer programs designed to ensure testing is affordable for patients, including:

• Financial assistance for patients with demonstrated financial need

• Tailored payment plans to accommodate certain specific financial circumstances

Decipher Bladder

Veracyte’s Decipher Bladder is covered by Medicare for patients with AJCC Stage I to IIIA bladder cancer. For more information, please contact the Decipher billing team at: 1.888.792.1601 and select option #3.

Decipher Assist

For more information on the Decipher Test and Decipher Assist, please contact the Decipher Assist team at:

888.792.1601 or download the Decipher Assist brochure.